ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AORT vs DRTS // ENTERPRISE SCALE & MARKET CAP

Artivion Inc. (NYSE) VS. Alpha Tau Medical Ltd. (NASDAQ) • 15-METRIC TALLY: AORT 4 — DRTS 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: DRTS
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AORT VS. DRTS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AORT DRTS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 64.40% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 4.50% -35.00% +39.50 AORT /roic <GO>
EV/EBITDA & P/E Valuation 19.3x — — TIE /valuation <GO>
Free Cash Flow Yield 0.07% -2.68% +2.75 AORT /fcf-yield <GO>
Operating Margin 7.60% — — TIE /operating-margins <GO>
Net Profit Margin 2.20% — — TIE /net-margins <GO>
Revenue Growth (YoY) 13.60% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.46 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 9/9 2/9 +7.00 AORT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 53.6 45.4 +8.20 AORT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 98.3x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $1.14B $1.22B -$80.6M DRTS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AORT REV DRTS REV AORT GROSS % DRTS GROSS % AORT FCF DRTS FCF
FY 2025 $441.3M $0 64.4% — $839.0K -$32.8M
FY 2024 $388.5M $0 64.0% — $11.0M -$22.0M
FY 2023 $354.0M $0 — — $18.8M -$18.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AORT // BETA —
DRTS // BETA —